Rebecca Sheets

2.7k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Rebecca Sheets is a scholar working on Infectious Diseases, Virology and Genetics. According to data from OpenAlex, Rebecca Sheets has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 9 papers in Virology and 9 papers in Genetics. Recurrent topics in Rebecca Sheets's work include Viral gastroenteritis research and epidemiology (10 papers), HIV Research and Treatment (9 papers) and Virus-based gene therapy research (9 papers). Rebecca Sheets is often cited by papers focused on Viral gastroenteritis research and epidemiology (10 papers), HIV Research and Treatment (9 papers) and Virus-based gene therapy research (9 papers). Rebecca Sheets collaborates with scholars based in United States, Switzerland and United Kingdom. Rebecca Sheets's co-authors include Se Jung Shin, James H. Strauss, Sean R. Eddy, Charles M. Rice, Edith M. Lenches, Phillip L. Gomez, Ivana Knežević, Charla Andrews, John C. Petricciani and Jason G. Gall and has published in prestigious journals such as Science, Cell and Clinical Microbiology Reviews.

In The Last Decade

Rebecca Sheets

35 papers receiving 1.8k citations

Hit Papers

Nucleotide Sequence of Yellow Fever Virus: Implications f... 1985 2026 1998 2012 1985 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Sheets United States 19 864 712 507 360 355 35 1.9k
Robin Levis United States 17 932 1.1× 570 0.8× 498 1.0× 493 1.4× 213 0.6× 23 1.9k
Juan García‐Arriaza Spain 25 811 0.9× 394 0.6× 587 1.2× 626 1.7× 413 1.2× 68 2.1k
Suh‐Chin Wu Taiwan 25 927 1.1× 699 1.0× 570 1.1× 579 1.6× 302 0.9× 84 1.9k
Jonathan F. Smith United States 26 1.8k 2.1× 958 1.3× 311 0.6× 648 1.8× 225 0.6× 35 2.4k
J. C. S. Clegg United Kingdom 26 1.0k 1.2× 406 0.6× 515 1.0× 487 1.4× 243 0.7× 41 1.8k
Kurt I. Kamrud United States 26 763 0.9× 377 0.5× 454 0.9× 407 1.1× 284 0.8× 43 1.6k
Pauline Aw Singapore 13 897 1.0× 567 0.8× 448 0.9× 285 0.8× 120 0.3× 14 1.9k
Mark D. Stenglein United States 27 1.3k 1.5× 437 0.6× 781 1.5× 708 2.0× 408 1.1× 79 2.8k
David Warrilow Australia 27 1.1k 1.3× 949 1.3× 335 0.7× 263 0.7× 123 0.3× 67 1.8k
К. В. Пугачев United States 23 1.1k 1.2× 1.1k 1.6× 195 0.4× 380 1.1× 111 0.3× 34 1.6k

Countries citing papers authored by Rebecca Sheets

Since Specialization
Citations

This map shows the geographic impact of Rebecca Sheets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Sheets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Sheets more than expected).

Fields of papers citing papers by Rebecca Sheets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Sheets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Sheets. The network helps show where Rebecca Sheets may publish in the future.

Co-authorship network of co-authors of Rebecca Sheets

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Sheets. A scholar is included among the top collaborators of Rebecca Sheets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Sheets. Rebecca Sheets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Condit, Richard, Anna‐Lise Williamson, Rebecca Sheets, et al.. (2016). Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine. 34(51). 6610–6616. 32 indexed citations
2.
Robertson, James S., Richard Condit, Stephen Seligman, et al.. (2016). Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis. Vaccine. 34(51). 6617–6625. 20 indexed citations
3.
Sheets, Rebecca, Jeffrey K. Pullen, Christopher Butler, et al.. (2015). Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: What are the “cGMP”?. Vaccine. 33(15). 1757–1766. 1 indexed citations
4.
Sheets, Rebecca, Tiequn Zhou, & Ivana Knežević. (2015). Review of efficacy trials of HIV-1/AIDS vaccines and regulatory lessons learned. Biologicals. 44(2). 73–89. 17 indexed citations
5.
Sheets, Rebecca, Tiequn Zhou, & Ivana Knežević. (2015). Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines – A review from a regulatory perspective. Biologicals. 44(2). 90–110. 6 indexed citations
6.
Sheets, Rebecca, et al.. (2015). Human challenge trials in vaccine development: Strasbourg, September 29 – October 1, 2014. Biologicals. 44(1). 37–50. 7 indexed citations
7.
Petricciani, John C., Rebecca Sheets, Elwyn Griffiths, & Ivana Knežević. (2014). Adventitious agents in viral vaccines: Lessons learned from 4 case studies. Biologicals. 42(5). 223–236. 41 indexed citations
8.
Chen, Robert T., Kenneth I. Berns, Louisa E. Chapman, et al.. (2014). The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Vaccine. 33(1). 73–75. 30 indexed citations
9.
Sheets, Rebecca. (2013). Opinion on adventitious agents testing for vaccines: Why do we worry so much about adventitious agents in vaccines?. Vaccine. 31(26). 2791–2795. 6 indexed citations
10.
Sheets, Rebecca, et al.. (2012). Adventitious agents, new technology, and risk assessment, 19–20 May 2011, Baltimore, MD. Biologicals. 40(2). 162–167. 4 indexed citations
11.
Mastelic, Béatris, D. J. Lewis, Hana Golding, et al.. (2012). Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety. Biologicals. 41(2). 115–124. 14 indexed citations
13.
Knežević, Ivana, Glyn Stacey, J.C. Petricciani, & Rebecca Sheets. (2009). Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Biologicals. 38(1). 162–169. 40 indexed citations
14.
Petricciani, John C. & Rebecca Sheets. (2008). An overview of animal cell substrates for biological products. Biologicals. 36(6). 359–362. 17 indexed citations
15.
Cheng, Cheng, Jason G. Gall, Wing-Pui Kong, et al.. (2007). Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells. PLoS Pathogens. 3(2). e25–e25. 65 indexed citations
16.
Rodriguez‐Chavez, Isaac R., Mary Allen, Edgar L. Hill, et al.. (2006). Current advances and challenges in HIV-1 vaccines. Current HIV/AIDS Reports. 3(1). 39–47. 11 indexed citations
17.
18.
Sheets, Rebecca, Judith A. Stein, T. Scott Manetz, et al.. (2006). Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-Inserts. Toxicological Sciences. 91(2). 620–630. 36 indexed citations
19.
Sheets, Rebecca & John C. Petricciani. (2004). Vaccine Cell Substrates 2004. Expert Review of Vaccines. 3(6). 633–638. 9 indexed citations
20.
Sheets, Rebecca & Karen L. Goldenthal. (1998). Workshop Report : Traditional Approach Preventive HIV Vaccines: What Are the Cell Substrate and Inactivation Issues?1. AIDS Research and Human Retroviruses. 14(7). 627–633. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026